Clinical Topics & News

Standardization of the Discharge Process for Inpatient Hematology and Oncology Using Plan-Do-Study-Act Methodology Improves Follow-Up and Patient Hand-Off

Author and Disclosure Information

 

References

Limitations

The absence of clinical endpoints was a limitation of this study. The present study was unable to evaluate the effect of the intervention on readmission rates, emergency department visits, hospital length of stay, cost, or mortality. Coordinating this multidisciplinary effort required much time and planning, and additional resources were not available to evaluate these clinical endpoints. Further studies are needed to evaluate whether the increased patient access and closer follow-up would result in improvement in these clinical endpoints. Another consideration for future improvement projects would be to include patients in the multidisciplinary team. The patient perspective would be invaluable in identifying gaps in care delivery and strategies aimed at improving care delivery.

Conclusions

This quality initiative to standardize the discharge process for the hematology and oncology service decreased time to the initial hematology and oncology follow-up appointment, improved communication between inpatient and outpatient teams, and decreased process variation. Timelier follow-up for this complex patient population likely will prevent clinical decompensation, delays in treatment, and directly improve patient access to care.

Acknowledgments

We thank our patients for whom we hope our process improvement efforts will ultimately benefit. We thank all the hematology and oncology staff at Edward Hines Jr. VA Hospital and Loyola University Medical Center residents and fellows who care for our patients and participated in the multidisciplinary team to improve care for our patients. We thank the following professionals for their uncompensated assistance in the coordination and execution of this initiative: Robert Kutter, MS, and Meghan O’Halloran, MD.

Pages

Recommended Reading

For cervical cancer screening, any strategy is acceptable
Federal Practitioner
The power and promise of social media in oncology
Federal Practitioner
Formal geriatric assessment should be routine
Federal Practitioner
Pediatric cancer survivors at risk for opioid misuse
Federal Practitioner
COVID-19 impact on breast cancer: Upfront endocrine Rx increased
Federal Practitioner
FDA okays upfront pembro for advanced HER2+ gastric cancer
Federal Practitioner
Possible obesity effect detected in cancer death rates
Federal Practitioner
Use of Comprehensive Geriatric Assessment in Oncology Patients to Guide Treatment Decisions and Predict Chemotherapy Toxicity
Federal Practitioner
Impact of an Oral Antineoplastic Renewal Clinic on Medication Possession Ratio and Cost-Savings
Federal Practitioner
Factors Associated with Radiation Toxicity and Survival in Patients with Presumed Early-Stage Non-Small Cell Lung Cancer Receiving Empiric Stereotactic Ablative Radiotherapy
Federal Practitioner